BACKGROUND: Catheter ablation is a curative treatment with excellent success and minimal complication rates for patients with supraventricular or ventricular arrhythmias. METHODS: The acute outcomes and complications of all catheter ablation procedures for supraventricular and ventricular arrhythmias performed at the Quebec Heart Institute (Sainte-Foy, Quebec) during a 14-year period from January 1, 1993, to December 31, 2006, were prospectively assessed. The ablation procedures were classified according to the arrhythmias induced using standard electrophysiological techniques and definitions. Immediate success and complication rates were prospectively included in the database. RESULTS: A total of 5330 patients had catheter ablation performed at the Institute during the period assessed. The mean (+/- SD) age of patients was 50 +/- 18 years (range four to 97 years), and 2340 patients (44%) were men. Most of the patients were younger than 75 years (group 1), and 487 (9%) were 75 years of age and older (group 2). Indications for ablations were as follows: atrioventricular nodal re-entry tachycardia (AVNRT) in 2263 patients, accessory pathways in 1147 patients, atrioventricular node ablation in 803 patients, typical atrial flutter in 377 patients and atrial tachycardia in 160 patients; 580 patients had other ablation procedures. The overall success rates were 81% for atrial tachycardia, 92% for accessory pathways or flutter, and 99% for AVNRT or atrioventricular node ablation. There was no difference in the success rates of the younger (group 1) and older (group 2) patients. Seventy-seven patients (1.4%) had complications, including 11 major events (myocardial infarction in one patient, pulmonary embolism in three patients and permanent pacemaker in seven patients). In patients undergoing AVNRT ablation, two had a permanent pacemaker implanted immediately after the procedure and three had a permanent pacemaker implanted at follow-up. CONCLUSIONS: The results confirm that radiofrequency ablation is safe and effective, supporting ablation therapy as a first-line therapy for the majority of patients with cardiac arrhythmias.
BACKGROUND: Catheter ablation is a curative treatment with excellent success and minimal complication rates for patients with supraventricular or ventricular arrhythmias. METHODS: The acute outcomes and complications of all catheter ablation procedures for supraventricular and ventricular arrhythmias performed at the Quebec Heart Institute (Sainte-Foy, Quebec) during a 14-year period from January 1, 1993, to December 31, 2006, were prospectively assessed. The ablation procedures were classified according to the arrhythmias induced using standard electrophysiological techniques and definitions. Immediate success and complication rates were prospectively included in the database. RESULTS: A total of 5330 patients had catheter ablation performed at the Institute during the period assessed. The mean (+/- SD) age of patients was 50 +/- 18 years (range four to 97 years), and 2340 patients (44%) were men. Most of the patients were younger than 75 years (group 1), and 487 (9%) were 75 years of age and older (group 2). Indications for ablations were as follows: atrioventricular nodal re-entry tachycardia (AVNRT) in 2263 patients, accessory pathways in 1147 patients, atrioventricular node ablation in 803 patients, typical atrial flutter in 377 patients and atrial tachycardia in 160 patients; 580 patients had other ablation procedures. The overall success rates were 81% for atrial tachycardia, 92% for accessory pathways or flutter, and 99% for AVNRT or atrioventricular node ablation. There was no difference in the success rates of the younger (group 1) and older (group 2) patients. Seventy-seven patients (1.4%) had complications, including 11 major events (myocardial infarction in one patient, pulmonary embolism in three patients and permanent pacemaker in seven patients). In patients undergoing AVNRT ablation, two had a permanent pacemaker implanted immediately after the procedure and three had a permanent pacemaker implanted at follow-up. CONCLUSIONS: The results confirm that radiofrequency ablation is safe and effective, supporting ablation therapy as a first-line therapy for the majority of patients with cardiac arrhythmias.
Authors: W M Jackman; X Z Wang; K J Friday; C A Roman; K P Moulton; K J Beckman; J H McClelland; N Twidale; H A Hazlitt; M I Prior Journal: N Engl J Med Date: 1991-06-06 Impact factor: 91.245
Authors: H Calkins; J Sousa; R el-Atassi; S Rosenheck; M de Buitleir; W H Kou; A H Kadish; J J Langberg; F Morady Journal: N Engl J Med Date: 1991-06-06 Impact factor: 91.245
Authors: C H Cheng; G D Sanders; M A Hlatky; P Heidenreich; K M McDonald; B K Lee; M S Larson; D K Owens Journal: Ann Intern Med Date: 2000-12-05 Impact factor: 25.391
Authors: S A Chen; C E Chiang; C T Tai; C C Cheng; C W Chiou; S H Lee; K C Ueng; Z C Wen; M S Chang Journal: Am J Cardiol Date: 1996-01-01 Impact factor: 2.778
Authors: W M Jackman; K J Beckman; J H McClelland; X Wang; K J Friday; C A Roman; K P Moulton; N Twidale; H A Hazlitt; M I Prior Journal: N Engl J Med Date: 1992-07-30 Impact factor: 91.245
Authors: Kathleen L Withers; Judith White; Grace Carolan-Rees; Hannah Patrick; Peter O'Callaghan; Stephen Murray; David Cunningham; Kathryn A Wood; Mauro Lencioni; Michael Griffith Journal: Europace Date: 2014-03-13 Impact factor: 5.214